11710 Federal Register / Vol. 87, No. 41 / Wednesday, March 2, 2022 / Notices 

Current Action: New Collection of 

Information. 

Type of Review: New. 

Affected Public: Individuals and 

Households, Businesses and 

Organizations, State, Local or Tribal 

Government. 

Estimated Number of Respondents: 

Below is a preliminary estimate of the 

aggregate burden hours for this new 

collection. GSA will provide refined 

estimates of burden in subsequent 

notices. 

Average Expected Annual Number of 

Activities: Approximately five types of 

customer experience activities such as 

feedback surveys, focus groups, user 

testing, and interviews. 

Average Number of Respondents per 

Activity: 1 response per respondent per 

activity. 

Annual Responses: 2,001,550. 

Average Minutes per Response: 2 

minutes—60 minutes, dependent upon 

activity. 

Burden Hours: GSA requests 

approximately 101,125 burden hours. 

Request for Comments: GSA invites 

comments on: (a) Whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden 

(including hours and cost) of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Comments submitted in 

response to this notice will be 

summarized and/or included in the 

request for OMB approval of this 

information collection; they also will 

become a matter of public record. 

Obtaining Copies of Proposals: 

Requesters may obtain a copy of the 

information collection documents from 

the GSA Regulatory Secretariat Division, 

by calling 202–501–4755 or emailing 

GSARegSec@gsa.gov. 

Beth Anne Killoran, 

Deputy Chief Information Officer. 

[FR Doc. 2022–04307 Filed 3–1–22; 8:45 am] 

BILLING CODE 6820–34–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP)—CE22–004: 

Research Grants To Prevent FirearmRelated Violence and Injuries; 

Amended Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Disease, Disability, 

and Injury Prevention and Control 

Special Emphasis Panel (SEP)—CE22– 

004, Panel A: Research Grants to 

Prevent Firearm-Related Violence and 

Injuries; April 4–5, 2022; CE22–004, 

Panel B1: Research Grants to Prevent 

Firearm-Related Violence and Injuries; 

April 6–8, 2022; CE22–004, Panel B2: 

Research Grants to Prevent FirearmRelated Violence and Injuries; April 6– 

8, 2022. The meeting was published in 

the Federal Register on February 16, 

2022, Volume 87, Number 32, page 

8841. 

The meeting is being amended to 

correct the meeting dates and should 

read as follows: 

CE22–004, Panel A: Research Grants 

to Prevent Firearm-Related Violence and 

Injuries; April 4–5, 2022; CE22–004, 

Panel B1: Research Grants to Prevent 

Firearm-Related Violence and Injuries; 

April 6–7, 2022; and CE22–004, Panel 

B2: Research Grants to Prevent FirearmRelated Violence and Injuries; April 6– 

7, 2022. The meeting is closed to the 

public. 

FOR FURTHER INFORMATION CONTACT: 

Mikel Walters, Ph.D., Scientific Review 

Officer, National Center for Injury 

Prevention and Control, CDC, 4770 

Buford Highway NE, Mailstop F–63, 

Atlanta, Georgia 30341, Telephone (404) 

639–0913, MWalters@cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–04340 Filed 3–1–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP)—CE22–009, 

Rigorous Evaluation of CommunityLevel Substance Use and Overdose 

Prevention Frameworks That 

Incorporate ACEs-Related Prevention 

Strategies; Amended Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Disease, Disability, 

and Injury Prevention and Control 

Special Emphasis Panel CE22–009, 

Rigorous Evaluation of CommunityLevel Substance Use and Overdose 

Prevention Frameworks that Incorporate 

ACEs-Related Prevention Strategies; 

April 26–27, 2022, 8:30 a.m.–5:30 p.m. 

EDT, via Web Conference, in the 

original FRN. The meeting was 

published in the Federal Register on 

January 14, 2022, Volume 87, Number 

10, page/s/2439. 

The meeting is being amended to 

change the meeting date and should 

read as follows: 

CE22–009, Rigorous Evaluation of 

Community-Level Substance Use and 

Overdose Prevention Frameworks that 

Incorporate ACEs-Related Prevention 

Strategies: April 26, 2022. 

The meeting is closed to the public. 

FOR FURTHER INFORMATION CONTACT: 

Aisha L. Wilkes, M.P.H., Scientific 

Review Official, National Center for 

Injury Prevention and Control, CDC, 

4770 Buford Highway NE, Mailstop 

S106–9, Atlanta, Georgia 30341, 

Telephone (404) 639–6473, AWilkes@

cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–04341 Filed 3–1–22; 8:45 am] 

BILLING CODE 4163–18–P 


lotter on DSK11XQN23PROD with NOTICES1